Basket | Login | Register

 
 
 
 

Phase II trials

Clinical Trials Watch

This section contains information about clinical trials that are:

  • Currently recruiting participants
  • Conducted at least in one European country
  • In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)

How many Phase II trials are reported in the CTW?

The CTW reports currently 9 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:

Study

Study sponsor

Name of the drug

Condition

Abvac40

Araclon Biotech S.L.

ABvac40

Amnestic mild cognitive impairment or very mild Alzheimer's disease

ACI-24-1801

AC Immune

ACI-24

Mild Alzheimer's disease

DESPIAD

University College London

CPHPC

Mild Alzheimer's disease

ETHERAL

Oryzon

ORY-2001

Mild-moderate Alzheimer's disease

LAURIET

Genentech

RO7105705

Moderate Alzheimer's disease

LM11A-31-BHS

PharmatrophiX Inc.

LM11A-31-BHS

Mild-moderate Alzheimer's disease

MAPT-CS1

Ionis Pharmaceuticals, Inc.

IONIS MAPTRx

Mild Alzheimer's disease

TANGO

Biogen

BIIB092

Early Alzheimer's disease

VALZ-PILOT

Hugo Lovheim

Valaciclovir

Early Alzheimer's disease

 

 
 

Last Updated: Monday 22 July 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options